Echo Therapeutics, Inc. announced earnings results for the third quarter ended September 30, 2015. For the quarter, the company reported net loss of $1.8 million or $0.16 per share, compared to $2.7 million or $0.21 per share, for the same period in 2014. The $900,000 decrease in net loss was a result of decreases in research and development (R&D) and selling, general and administrative (S,G&A) expenses.
Echo Therapeutics, Inc.
Equities
ECTE
US27876L2060
Advanced Medical Equipment & Technology
1st Jan change | Capi. | |
---|---|---|
+8.07% | 219B | |
+7.87% | 185B | |
+12.75% | 135B | |
+25.79% | 107B | |
+11.59% | 51.28B | |
+4.88% | 51.01B | |
+2.71% | 41.85B | |
+4.90% | 37.02B | |
+23.75% | 31.27B |